Cresilon
Develops plant-based hemostatic gels to stop bleeding instantly.
biotechmedical-devices
Company facts
Series B-stage
- Founded
- 2010
- Employees
- 93
- Headquarters
- United States
- Type
- Private
- Funding
- Series B · $113M · 2025
Open positions
1 job
4 views 3 months ago
Production Technician I, 2nd Shift Full-Time Monday-Friday
Open 95d North AmericaFull-time No extra questions
United States
Brooklyn, New YorkManufactures medical devices in a cleanroom, operating equipment and following cGMP to produce hemostatic hydrogel products for animal health.
Near Miss Reporting
20 – 24 $ / hr